Mark B. Evers

1.4k total citations
26 papers, 1.1k citations indexed

About

Mark B. Evers is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Mark B. Evers has authored 26 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 9 papers in Epidemiology and 8 papers in Neurology. Recurrent topics in Mark B. Evers's work include Lung Cancer Research Studies (10 papers), Neuroendocrine Tumor Research Advances (8 papers) and Neuroblastoma Research and Treatments (8 papers). Mark B. Evers is often cited by papers focused on Lung Cancer Research Studies (10 papers), Neuroendocrine Tumor Research Advances (8 papers) and Neuroblastoma Research and Treatments (8 papers). Mark B. Evers collaborates with scholars based in United States, United Kingdom and Canada. Mark B. Evers's co-authors include Chendil Damodaran, Sowmyalakshmi Srinivasan, Raj Kumar, Srinivas V. Koduru, Heidi L. Weiss, Piotr Rychahou, Yimei Han, Lindsey N. Jackson, Hung Q. Doan and Bill A. Rampy and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Health Affairs.

In The Last Decade

Mark B. Evers

25 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark B. Evers United States 13 351 331 192 190 179 26 1.1k
Linlin Pan China 12 239 0.7× 522 1.6× 220 1.1× 146 0.8× 99 0.6× 40 1.1k
Hao Jin China 22 303 0.9× 207 0.6× 171 0.9× 181 1.0× 455 2.5× 90 1.3k
Ming‐Hui Tai China 17 342 1.0× 176 0.5× 168 0.9× 199 1.0× 284 1.6× 46 1.1k
Arafat Tfayli Lebanon 21 364 1.0× 522 1.6× 85 0.4× 277 1.5× 73 0.4× 95 1.3k
Jue Wang China 17 194 0.6× 153 0.5× 166 0.9× 89 0.5× 200 1.1× 60 855
Connie M. Szczepanek United States 6 306 0.9× 238 0.7× 52 0.3× 282 1.5× 232 1.3× 10 1.8k
Zhaoquan Huang China 21 489 1.4× 129 0.4× 86 0.4× 224 1.2× 78 0.4× 48 953
Rebecca E. Graff United States 19 424 1.2× 383 1.2× 124 0.6× 343 1.8× 113 0.6× 66 1.4k
Alfredo Tartarone Italy 17 236 0.7× 432 1.3× 88 0.5× 132 0.7× 87 0.5× 61 1.1k
Yuan‐Ching Chang Taiwan 18 300 0.9× 365 1.1× 196 1.0× 278 1.5× 163 0.9× 52 1.4k

Countries citing papers authored by Mark B. Evers

Since Specialization
Citations

This map shows the geographic impact of Mark B. Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Evers more than expected).

Fields of papers citing papers by Mark B. Evers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Evers. The network helps show where Mark B. Evers may publish in the future.

Co-authorship network of co-authors of Mark B. Evers

This figure shows the co-authorship network connecting the top 25 collaborators of Mark B. Evers. A scholar is included among the top collaborators of Mark B. Evers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark B. Evers. Mark B. Evers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kolesar, Jill, Donglin Yan, Zhonglin Hao, et al.. (2023). Abstract CT221: Phase II of frontline maintenance rucaparib in combination with nivolumab in ES SCLC. Cancer Research. 83(8_Supplement). CT221–CT221. 1 indexed citations
2.
3.
Gan, Tong J., Quan Chen, Bin Huang, et al.. (2020). Nonadherence to Standard of Care for Locally Advanced Colon Cancer as a Contributory Factor for High Mortality Rates in Kentucky. Journal of the American College of Surgeons. 230(4). 428–439. 9 indexed citations
4.
Gan, Tong J., Quan Chen, Bin Huang, et al.. (2019). Impact of the Affordable Care Act on Colorectal Cancer Screening, Incidence, and Survival in Kentucky. Journal of the American College of Surgeons. 228(4). 342–353e1. 52 indexed citations
5.
Chauhan, Aman, Riham El Khouli, Mark B. Evers, Elizabeth Oates, & Lowell Anthony. (2019). Impact of Ga-68 DOTATATE imaging on clinical management of neuroendocrine tumor patients: Post-FDA-approval analysis of first 200 clinical patients.. Journal of Clinical Oncology. 37(4_suppl). 238–238. 1 indexed citations
6.
Chauhan, Aman, Susanne M. Arnold, Jianrong Wu, et al.. (2019). Clinical efficacy and toxicity data on phase I study of fosbretabulin in combination with everolimus in neuroendocrine tumors.. Journal of Clinical Oncology. 37(15_suppl). 4114–4114. 3 indexed citations
7.
Zaytseva, Yekaterina Y., Piotr Rychahou, Timothy Scott, et al.. (2018). Preclinical evaluation of novel fatty acid synthase inhibitors in primary colorectal cancer cells and a patient-derived xenograft model of colorectal cancer. Oncotarget. 9(37). 24787–24800. 97 indexed citations
8.
Chauhan, Aman, Qian Yu, Bin Huang, et al.. (2018). Global burden of neuroendocrine tumors and changing incidence in Kentucky. Oncotarget. 9(27). 19245–19254. 39 indexed citations
9.
Chauhan, Aman, et al.. (2017). Immune checkpoint inhibitors in neuroendocrine tumors: A single institution experience with review of literature. Oncotarget. 9(10). 8801–8809. 26 indexed citations
10.
Evers, Mark B.. (2015). The Evolving Role of the Surgeon Scientist. Journal of the American College of Surgeons. 220(4). 387–395. 19 indexed citations
11.
Johnson, Sara M., Pat Gulhati, Bill A. Rampy, et al.. (2010). Novel Expression Patterns of PI3K/Akt/mTOR Signaling Pathway Components in Colorectal Cancer. Journal of the American College of Surgeons. 210(5). 767–776. 207 indexed citations
12.
Carman, Kristin L., et al.. (2010). Evidence That Consumers Are Skeptical About Evidence-Based Health Care. Health Affairs. 29(7). 1400–1406. 117 indexed citations
13.
Larson, Shawn D., Lindsey N. Jackson, Taylor S. Riall, et al.. (2007). Increased Incidence of Well-Differentiated Thyroid Cancer Associated with Hashimoto Thyroiditis and the Role of the PI3k/Akt Pathway. Journal of the American College of Surgeons. 204(5). 764–773. 177 indexed citations
14.
Rychahou, Piotr, et al.. (2004). RNAi-mediated inhibition of cyclin D1 decreases colon cancer cell proliferation and MMP protein expression. Journal of the American College of Surgeons. 199(3). 11–11. 1 indexed citations
15.
Rychahou, Piotr, C.A. Murillo, & Mark B. Evers. (2004). Downregulation of the PI3k/Akt pathway leads to decreased invasion of the human colon cancer cells. Journal of the American College of Surgeons. 199(3). 10–10. 2 indexed citations
16.
Kang, JungHee, Piotr Rychahou, Jingbo Qiao, Mark B. Evers, & Dai H. Chung. (2004). MYCN RNA interference decreases anti-apoptotic gene expression and proliferation of neuroblastomas. Journal of the American College of Surgeons. 199(3). 54–54.
17.
Evers, Mark B., Irving L. Weissman, Alan W. Flake, Viviane Tabar, & Richard D. Weisel. (2003). Stem Cells in Clinical Practice. Journal of the American College of Surgeons. 197(3). 458–478. 12 indexed citations
18.
Ethridge, Richard T., Koji Hashimoto, Dai H. Chung, et al.. (2002). Selective Inhibition of NF-κB Attenuates the Severity of Cerulein-Induced Acute Pancreatitis. Journal of the American College of Surgeons. 195(4). 497–505. 85 indexed citations
19.
Kim, Sung‐Hoon, et al.. (2000). Expression and functional regulation of the gastrin-releasing peptide (GRP) receptor in the neuroblastoma cell line IMR-32. Journal of the American College of Surgeons. 191(4). S42–S43. 1 indexed citations
20.
Evers, Mark B., et al.. (1988). Multiple adenocarcinomas of the colon and rectum. Diseases of the Colon & Rectum. 31(7). 518–522. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linlin Pan Breakdown of academic impact, for papers by Hao Jin Breakdown of academic impact, for papers by Ming‐Hui Tai Breakdown of academic impact, for papers by Arafat Tfayli Breakdown of academic impact, for papers by Jue Wang Breakdown of academic impact, for papers by Connie M. Szczepanek Breakdown of academic impact, for papers by Zhaoquan Huang Breakdown of academic impact, for papers by Rebecca E. Graff Breakdown of academic impact, for papers by Alfredo Tartarone Breakdown of academic impact, for papers by Yuan‐Ching Chang
Rankless by CCL
2026